CA2930117A1 - Peptides that stimulate subcutaneous adipogenesis - Google Patents

Peptides that stimulate subcutaneous adipogenesis Download PDF

Info

Publication number
CA2930117A1
CA2930117A1 CA2930117A CA2930117A CA2930117A1 CA 2930117 A1 CA2930117 A1 CA 2930117A1 CA 2930117 A CA2930117 A CA 2930117A CA 2930117 A CA2930117 A CA 2930117A CA 2930117 A1 CA2930117 A1 CA 2930117A1
Authority
CA
Canada
Prior art keywords
seq
composition
peptide
amino acid
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2930117A
Other languages
English (en)
French (fr)
Inventor
Seyed Bahram Bahrami
Mina J. Bissell
Eva A. Turley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California, San Diego
Original Assignee
University of California, San Diego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, San Diego filed Critical University of California, San Diego
Publication of CA2930117A1 publication Critical patent/CA2930117A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/001—Preparations for care of the lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
CA2930117A 2012-11-25 2013-11-25 Peptides that stimulate subcutaneous adipogenesis Abandoned CA2930117A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261729626P 2012-11-25 2012-11-25
US61/729,626 2012-11-25
US201361778084P 2013-03-12 2013-03-12
US61/778,084 2013-03-12
PCT/US2013/071719 WO2014082042A2 (en) 2012-11-25 2013-11-25 Peptides that stimulate subcutaneous adipogenesis

Publications (1)

Publication Number Publication Date
CA2930117A1 true CA2930117A1 (en) 2014-05-30

Family

ID=49753509

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2930117A Abandoned CA2930117A1 (en) 2012-11-25 2013-11-25 Peptides that stimulate subcutaneous adipogenesis

Country Status (11)

Country Link
US (2) US10766927B2 (enExample)
EP (1) EP2922869B1 (enExample)
JP (1) JP2016501866A (enExample)
KR (1) KR20150088841A (enExample)
CN (1) CN105008396A (enExample)
AU (1) AU2013347797A1 (enExample)
CA (1) CA2930117A1 (enExample)
HK (1) HK1216895A1 (enExample)
IL (1) IL239008A0 (enExample)
RU (1) RU2015123315A (enExample)
WO (1) WO2014082042A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10766927B2 (en) 2012-11-25 2020-09-08 The Regents Of The University Of California Peptides that stimulate subcutaneous adipogenesis
US10844102B2 (en) 2014-05-28 2020-11-24 The Regents Of The University Of California Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
WO2016151478A1 (en) 2015-03-20 2016-09-29 London Health Sciences Centre Research Inc. Stapled peptides and uses thereof
MX2017013196A (es) * 2015-04-17 2018-06-19 Symic Ip Llc Bioconjugados y usos de los mismos.
KR102208853B1 (ko) * 2018-05-08 2021-01-28 오션펩 주식회사 주름개선 효능을 갖는 펩티드
KR102285956B1 (ko) * 2018-11-26 2021-08-04 한국해양과학기술원 지방 생성을 자극하는 펩타이드, 조성 및 방법
CN114081861B (zh) * 2021-11-19 2023-10-31 和泓尚医(成都)生物科技有限公司 一种干细胞外泌体与复合肽抗衰制剂及其制备方法和应用
GB202211043D0 (en) * 2022-07-28 2022-09-14 Univ Birmingham Peptide agonist
EP4777520A1 (en) * 2023-09-14 2026-07-22 University of Florida Research Foundation, Incorporated Methods of use for rhamm-derived peptides and rhamm-derived peptide mimetics

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA175473A (en) * 1917-01-08 1917-03-06 Clarence G. Cashman Reamer head
GB9207949D0 (en) 1992-04-09 1992-05-27 Univ Manitoba Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
AU6081094A (en) * 1992-12-30 1994-08-15 Matthias Rath Synthetic oligopeptides analogous to protein signal sequences methods of identification and methods of use
GB9420740D0 (en) 1994-10-14 1994-11-30 Univ Manitoba Sequence of the hyaluronan receptor gene
US6127525A (en) 1995-02-21 2000-10-03 Cornell Research Foundation, Inc. Chimeric adenoviral coat protein and methods of using same
CA2166155C (en) 1995-12-27 2008-02-05 Eva Anne Turley Agents binding to hyaluronic acid binding domains and the use thereof
GB9607441D0 (en) * 1996-04-10 1996-06-12 Univ Manitoba Human hyaluronan receptor
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
CA2237051A1 (en) 1997-12-19 1999-06-19 Eva A. Turley Enhanced affinity hyaluronan binding peptides
US6211149B1 (en) * 1998-08-03 2001-04-03 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors of formation of protease resistant prion protein
GB9811962D0 (en) 1998-06-03 1998-07-29 Janssen Pharmaceutica Nv Vertebrate homologue of UNC-53 protein of C.elegans
EP1151012A4 (en) 1998-11-19 2003-01-08 Smithkline Beecham Corp ANTAGONIST ANTIBODIES OF RHAMM
US6153432A (en) 1999-01-29 2000-11-28 Zen-Bio, Inc Methods for the differentiation of human preadipocytes into adipocytes
JP2000217576A (ja) 1999-02-02 2000-08-08 Herikkusu Kenkyusho:Kk 脂肪細胞への分化を誘導する方法、並びに脂肪細胞への分化を制御する化合物およびそのスクリーニング方法
US6911429B2 (en) 1999-04-01 2005-06-28 Transition Therapeutics Inc. Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
US6864235B1 (en) 1999-04-01 2005-03-08 Eva A. Turley Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
US20070116669A1 (en) * 2002-09-13 2007-05-24 Chemokine Therapeutics Corporation Interferon-inducible protein-10 (IP-10 or CXCL10) chemokine analogs for the treatment of human diseases
US20040037834A1 (en) * 2000-04-20 2004-02-26 Woloski B. Michael R. Rhamm peptide conjugates
US7601825B2 (en) * 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
CN1541106A (zh) 2001-06-11 2004-10-27 转新疗法公司 用维生素b12和治疗剂联合治疗病毒性、增殖性和炎性疾病的方法
BR0210539A (pt) 2001-06-19 2005-04-26 Us Gov Health & Human Serv Processos de seleção e uso de vacinas de vetor antiartrópode
JP2005503381A (ja) 2001-08-15 2005-02-03 岐阜県 脂肪細胞分化阻害作用を有するセスキテルペノイド誘導体
US20030170755A1 (en) 2001-09-26 2003-09-11 Ludwig Institute For Cancer Research Tumor-associated antigen RHAMM
WO2003031640A2 (en) 2001-10-06 2003-04-17 Boston Medical Center Corporation Preadipocyte cell strains and uses therefore
JP2005513026A (ja) 2001-11-15 2005-05-12 インサイト サン ディエゴ インコーポレイテッド 高コレステロール血症、異脂肪血症および他の代謝障害；癌、および他の疾患を治療するｎ−置換複素環
EP1462518B1 (en) 2001-12-07 2009-04-08 Nissui Pharmaceutical Co., Ltd. Adipocyte differentiation-associated gene and protein
FR2834996B1 (fr) 2002-01-18 2004-12-03 Genfit S A Methode d'identification de substances capables de moduler la differenciation adipocytaire
US7196108B2 (en) 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
SE0201863D0 (en) * 2002-06-18 2002-06-18 Cepep Ab Cell penetrating peptides
CA2513143A1 (en) 2002-07-01 2004-01-08 Tufts University Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
US7879544B2 (en) 2002-07-29 2011-02-01 Hmgene Inc. Methods of identifying adipocyte specific genes, the genes identified, and their uses
KR20060041163A (ko) 2003-04-28 2006-05-11 세쿠오이아 파마큐티컬스 인코오퍼레이티드 코로나바이러스에 의한 감염을 치료, 조절 및 예방하기위한 항바이러스 제제들
WO2005007078A2 (en) 2003-04-30 2005-01-27 The Boards Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (sars)
AU2004266642A1 (en) * 2003-08-12 2005-03-03 University Of Utah Research Foundation Heparin binding proteins: sensors for heparin detection
DK1677735T3 (da) 2003-10-17 2014-10-27 Joslin Diabetes Center Inc Fremgangsmåder og sammensætninger til modulering af adipocytfunktion
KR20070004560A (ko) 2003-12-05 2007-01-09 노오쓰웨스턴 유니버시티 성장 인자 전달을 위한 자가조립 펩티드 친양매성 화합물들및 관련 방법들
EP1896386B1 (en) 2005-06-08 2012-09-05 Cangene Corporation Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
US20090176306A1 (en) 2005-06-10 2009-07-09 Toshio Taira Method of inducing differentiation from visceral preadipocyte to visceral adipocyte
US20070179085A1 (en) 2005-07-20 2007-08-02 Savani Rashmin C Modulation of rhamm-caveolin/lipid raft interactions to affect development, responses to tissue injury, angiogenesis, tumorigenesis, metastasis and growth factor/cytokine responses
US20070292869A1 (en) 2006-03-02 2007-12-20 Ppd Biomarker Discovery Sciences, Llc Compositions and Methods for Analyzing Renal Cancer
US8066691B2 (en) 2006-04-21 2011-11-29 Khouri Roger K Method and system for preparing soft tissue for grafting, enhancing grafting results, and grafting autologous fat to soft tissue such as the breast
BRPI0717458A8 (pt) 2006-10-20 2017-06-06 Laboratoires Inneov Utilização cosmética por via oral e/ou parenteral da glicosamina e da associação da glicosamina e pelo menos um composto polifenol, processo cosmético, composição para administração oral, e, complemento alimentar ou alimento funcional
WO2008140586A2 (en) * 2006-11-21 2008-11-20 The Regents Of The University Of California Modulation of rhamm (cd168) for selective adipose tissue development
US20100062000A1 (en) 2006-11-21 2010-03-11 The Regents Of The University Of California Rhamm, a Co-Receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations
EP1967524A1 (en) 2007-03-06 2008-09-10 Friesland Brands B.V. Methods for producing ACE-inhibitory peptides from whey and peptides obtained thereby
WO2009036246A2 (en) 2007-09-14 2009-03-19 Immunotope, Inc. Immunogens that induce cytotoxic t-lymphocytes and their use in prevention, treatment, and diagnosis of cancer
WO2009039854A2 (en) * 2007-09-27 2009-04-02 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
EP2207810A4 (en) 2007-10-12 2011-12-07 London Health Sciences Ct Res Inc COMPOSITIONS WHICH INFLUENCE THE HYALURONIC ACID-ACTIVITY
KR20100093523A (ko) * 2007-11-06 2010-08-25 주식회사 프로셀제약 세포투과성 ｒｕｎｘ３ 재조합 단백질, 이를 코딩하는 폴리뉴클레오티드 및 이를 유효성분으로 함유하는 항암 조성물
US8216828B2 (en) 2008-05-30 2012-07-10 Corning Incorporated Assembly of cell culture vessels
AU2011261107B2 (en) 2010-05-31 2016-04-14 London Health Sciences Centre Research Inc. RHAMM binding peptides
US20120076810A1 (en) * 2010-09-01 2012-03-29 Poland Gregory A Vaccinia virus polypeptides
EP2611908A4 (en) * 2010-09-01 2014-04-02 Univ California Cell culture screen for agents that control adipogenesis and myofibroblast differentiation
BR112013005448A2 (pt) 2010-09-07 2019-09-24 Oncotherapy Science Inc peptídeos de ttll4 e vacinas contendo os mesmos.
US10766927B2 (en) 2012-11-25 2020-09-08 The Regents Of The University Of California Peptides that stimulate subcutaneous adipogenesis
US10844102B2 (en) 2014-05-28 2020-11-24 The Regents Of The University Of California Peptides, compositions, and methods for stimulating subcutaneous adipogenesis

Also Published As

Publication number Publication date
US20140179616A1 (en) 2014-06-26
EP2922869B1 (en) 2017-09-27
AU2013347797A1 (en) 2015-07-02
HK1216895A1 (zh) 2016-12-09
US20150284433A1 (en) 2015-10-08
WO2014082042A3 (en) 2014-07-24
EP2922869A2 (en) 2015-09-30
CN105008396A (zh) 2015-10-28
US10494402B2 (en) 2019-12-03
JP2016501866A (ja) 2016-01-21
KR20150088841A (ko) 2015-08-03
IL239008A0 (en) 2015-07-30
WO2014082042A2 (en) 2014-05-30
US10766927B2 (en) 2020-09-08
RU2015123315A (ru) 2017-01-10

Similar Documents

Publication Publication Date Title
US10494402B2 (en) Peptides that stimulate subcutaneous adipogenesis
JP2023527356A (ja) 副甲状腺機能低下症を処置するためのｐｔｈ類似体
JP7183164B2 (ja) Ｐａｃ１受容体作動薬（ｍａｘｃａｐ）及びその用途
JP2022514114A (ja) ニコチン性アセチルコリン受容体ペプチドアンタゴニストであるコノトキシン組成物、およびこれに関連する方法
US10844102B2 (en) Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
KR101092915B1 (ko) 성장인자―유래 펩타이드 및 이의 용도
CN102438580B (zh) 钙结合剂诱导毛发生长和/或甲生长
EP4313100A2 (en) Peptides and methods for reducing skin pigmentation
WO2019055431A1 (en) PEPTIDE INHIBITORS OF INSULIN DEGRADATION ENZYME
US12139555B2 (en) Peptides and compositions for inhibiting hair growth
AU2018353934B2 (en) Peptide for inhibiting skin inflammation and composition for preventing or treating skin inflammation containing the same
EP4236980A1 (en) Novel klotho interaction site in the c-terminus of fgf23
HK40015225A (en) Composition and methods for preventing radiation injury and promoting tissue regeneration
JPWO2012157674A1 (ja) 環状ペプチド化合物またはその薬理的に許容される塩、その製造方法、及びその用途
KR20110074507A (ko) 성장인자―유래 펩타이드 및 이의 용도

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20181127